eb8018
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT02998190)
Timeline
Indications
Mechanism of action
- FimHINHIBITOR
fimH inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- eb8018
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03943446 | Phase 2 | Sep 9, 2019 | Millennium Pharmaceuticals, Takeda |
| NCT03709628 | Phase 1 | Mar 7, 2018 | Enterome |
| NCT02998190 | Phase 1 | Dec 1, 2016 | Enterome, Quotient |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Enterome | For profit | 2 | 2 | 1 | 2016 |
| Millennium Pharmaceuticals | For profit | 1 | 1 | 1 | 2019 |
| Quotient | For profit | 1 | 0 | 1 | 2016 |
| Takeda | For profit | 1 | 0 | 1 | 2019 |
4 organizations
Page 1 / 1